AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial magnetic stimulation
Description: Before the stimulation, identification of a motor hotspot and active motor threshold (AMT) will be performed. The TMS will be applied on the intermittent theta-burst modality (iTBS), i. e., 2 s of TBS trains (30 pulses) repeated every 10 s for 190 s, with a total number of 600 pulses (Huang et al, 2005). The whole TMS session, including preparation, will last up to 1h.~The sham TMS follows the same procedure of the active TMS without stimulating cortical tissue
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: Anatomical and functional images will be acquired and review by an experienced neuro-radiologist.
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: MRI
Description: Anatomical and functional images will be acquired and review by an experienced neuro-radiologist.
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuronavigation
Description: The neuronavigation system will allow to guide the stimulation using the individual anatomical MRI acquired with MRI, and to record the position and orientation of the coil during successive stimulations
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Neuronavigation
Description: The neuronavigation system will allow to guide the stimulation using the individual anatomical MRI acquired with MRI, and to record the position and orientation of the coil during successive stimulations
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Eye-tracking
Description: Eye movements and follow a person's gaze will be recorded during visualization of stimuli presented in the screen by analyzing images of the eye captured by an infrared camera
Study NCT04442061 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Eye-tracking
Description: Eye movements and follow a person's gaze will be recorded during visualization of stimuli presented in the screen by analyzing images of the eye captured by an infrared camera
Study NCT04442061 — intervention group
Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: Salivary samples
Description: The DNA will be extracted from the salivary sample to genotyping analyses on the BDNF (Val66Met) and COMT (Val158Met) polymorphism
Study NCT04442061 — intervention group
Intervention type: GENETIC
Group type: SHAM_COMPARATOR
Intervention: Salivary samples
Description: The DNA will be extracted from the salivary sample to genotyping analyses on the BDNF (Val66Met) and COMT (Val158Met) polymorphism
Study NCT04442061 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical scales
Description: CGI, E-CAR and ABC will be used for behavior and clinical evaluation
Study NCT04442061 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Clinical scales
Description: CGI, E-CAR and ABC will be used for behavior and clinical evaluation
Study NCT05458947 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulsed wound irrigation (PWI)
Description: necrotic wound is irrigated with normal saline (0.9%) with an 8-12 pounds per square inch pressure (PSI) to provide a mechanical force to loosen necrotic tissue for wound healing
Study NCT05458947 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: electrical stimulation (ES)
Description: high volt pulsed current (HVPC) is most effective in wound healing while decreasing risk of adverse skin reactions or mild burns under the electrodes
Study NCT05458947 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: electrical stimulation (ES) and pulsed wound irrigation (PWI)
Description: necrotic wound is irrigated with normal saline (0.9%) with an 8-12 pounds per square inch pressure (PSI) to provide a mechanical force to loosen necrotic tissue for wound healing and high volt pulsed current (HVPC) is most effective in wound healing while decreasing risk of adverse skin reactions or mild burns under the electrodes
Study NCT06013449 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed Electromagnetic Field (PEMF) Device
Description: Pulsed Electromagnetic Field (PEMF) Device BEMER Device consist of a total body mat (B. BODY) plus a targeted pelvic mat (B.PAD), and a Control Unit which powers the device and logs usage. Both B.BODY and B.PAD must be plugged into the Control Unit simultaneously and activated individually. B. Body must be placed on a flat surface (i.e. bed, floor, reclining chair etc.) for best results.
Study NCT06013449 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Pulsed Electromagnetic Feild (PEMF) Device
Description: The sham PEMF device appears identical to the BEMER PEMF device, with all of the same components and accessories, but does not emit a pulsed electromagnetic field.
Study NCT05010317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance based therapy
Description: This is a behavioral intervention that is aimed at building psychological flexibility among adolescents. It involves careful use of language, metaphors, experiential learning and mindfulness to develop skills that support values guided living. Participants learn to relate with their inner thoughts, feelings and urges in an open and elaborative way as conscious human beings and make choices that improve their lives even in the presence of such difficult experiences.
Study NCT05010317 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Usual clinic based counselling offered as routine care to adolescents
Study NCT05010317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Usual clinic based counselling offered as routine care to adolescents
Study NCT06494592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Participants in the aerobic exercise intervention group will engage in a virtual aerobic exercise intervention three times a week for 12 weeks for a 30-minute session (5 minute warm up, 20 minutes of aerobic exercise, 5 minutes cooldown) and will receive information about the session prior to their appointment. Sessions have a goal of reaching at least 20 minutes of supervised exercise performed at 80% of the heart rate at symptom threshold.
Study NCT06494592 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Balance Exercise
Description: Participants in the balance exercise intervention group will participate in a staff-led virtual session three times a week for 12 weeks for a 30-minute session and will receive information about the session prior to their appointment. This group will focus on improving balance, with some additional work on flexibility and strength.
Study NCT05660668 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transbond LR
Description: cleaning the lingual surface using oil free pumice then apply acid etch 35% phosphoric acid for 20 second then rinse then Transbond LR will be applied directly on the fixed retainer and lingual surface of the teeth then light cured.
Study NCT05660668 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transbond XT
Description: cleaning the lingual surface using oil free pumice then apply acid etch 35% phosphoric acid for 20 second then rinse then Transbond XT will be applied directly on the fixed retainer and lingual surface of the teeth then light cured.
Study NCT05807035 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Radvax
Description: Vaccine extracted from patient's own tumour tissue formulated with polysaccharide adjuvant
Study NCT04769674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory Integration Intervention through the STAR Frame of Reference
Description: The individualized therapy program will be based on the results of the comprehensive evaluation. Intervention aligns with the STAR Frame of Reference fidelity measure and Ayres Fidelity Measure.
Study NCT05061147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MAX-40279-01
Description: Drug: AZA AZA will be administered at 75 mg/m\^2 by subcutaneous injection for 7 consecutive days from D1 to D7 in 28-day treatment cycles.~Other Name: Azacitidine~Drug: Max-40279-01 Max-40279-01 will be administered as a combination of multiple oral capsules containing 5 and 25 mg. An alternate combination of 35 mg, 50 mg and 60 mg Max-40279-01 twice a day may be utilized.~Other Name: NA
Study NCT06175208 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques
Description: Every participant may be randomized to either the iEFT, iMMI, or WLC group. All patients will be randomised to one of the three groups and be involved in a 6-week trajectory.
Study NCT06175208 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness Meditation
Description: Every participant may be randomized to either the iEFT, iMMI, or WLC group. All patients will be randomised to one of the three groups and be involved in a 6-week trajectory.
Study NCT04953143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LiverPal Intervention
Description: Inpatient longitudinal palliative care intervention~- Patients will complete baseline assessments and will be followed by the palliative care clinicians delivering the LiverPal intervention during each of their hospitalizations over a 3 month period~LiverPal intervention domains include the following:~* Therapeutic relationship~* Symptom management~* Coping with illness~* Prognostic awareness and illness understanding~* Treatment decision-making~* End-of-life care
Study NCT05075863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Letrozole as 5mg from day 3 to 7 of menstrual cycle
Study NCT04062721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Chemotherapy (at the investigator's choice) for ≥ 2 months before RFA (with controlled disease) and resumed 4-6 weeks after RFA to achieve 6-month total duration.
Study NCT04062721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Description: Complete macroscopic ablation by RFA.
Study NCT04062721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: In situ immunotherapy
Description: Hydrogel combining TLR or NOD2 agonist and GM-CSF will be injected in 1, 2 or 3 distinct lesions after RFA.
Study NCT05399147 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: fiberoptic intubation classic technique
Description: classic fiberoptic intubation
Study NCT05399147 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: fiberoptic intubation tube 1st technique
Description: tube 1st technique
Study NCT04332926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tobacco product administration and assessment
Description: 4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
Study NCT04332926 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tobacco product administration and assessment
Description: 4 sample puffs, followed by a 60 minute rest period, hypothetical drug purchase tasks, followed by progressive ratio tasks (single product and two products, with 60 minute rest in between) where participants work to earn puffs of tobacco products; preceded and followed by physiological and subjective assessment
Study NCT05079256 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 595 nm Pulsed dye laser (Candela V-beam perfecta)
Description: 595 nm pulsed dye laser therapy. 2 treatments Fluence \~ 6 - 9 J/cm\^2 Pulse duration \~ 0.45 - 3.0 ms 33% overlap.
Study NCT05194358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stabilized Isoamyl Nitrite (SIAN)
Description: SIAN is comprised of isoamyl nitrite (IAN) stabilized with 4% by weight epoxidized linseed oil (ELSO) and administered by intranasal (IN) delivery as a nasal spray.~A syringe-based spray device will be used to administer the SIAN product. This syringe-based spray device, consists of a Hamilton type syringe connected to a tip that functions as an atomizer, to provide an optimal spray plume for nasal absorption while minimizing exposure to lungs.
Study NCT05125302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ubrogepant
Description: Oral Tablet
Study NCT05392530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan
Description: Macitentan film coated tablets will be administered orally as per assigned treatment sequence.
Study NCT06039137 — intervention group
Intervention type: DRUG
Intervention: Cetirizine
Description: Subjects were treated with a paclitaxel premedication regimen which contained oral cetirizine instead of intravenous clemastine
Study NCT06039137 — intervention group
Intervention type: DRUG
Intervention: Clemastine IV
Description: Subjects were treated with paclitaxel premedication containing clemastine 2 mg IV
Study NCT04912479 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: connected watch
Description: connected watch that provide to patients with information on their sleep quality and their performed activities
Study NCT06265337 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Lactate
Description: Lactate in an OGTT (300 mL lactate drink = 25 g D/L-lactate bound to Na) =LAC with a stable isotope glucose tracer (D2-glucose) added to measure glucose.
Study NCT06265337 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactate
Description: Lactate in an OGTT (300 mL lactate drink = 25 g D/L-lactate bound to Na) =LAC with a stable isotope glucose tracer (D2-glucose) added to measure glucose.
Study NCT06265337 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo in an OGTT (300 mL salt water, NaCl) =CTR with a stable isotope glucose tracer (D2-glucose) added to measure glucose.
Study NCT06265337 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo in an OGTT (300 mL salt water, NaCl) =CTR with a stable isotope glucose tracer (D2-glucose) added to measure glucose.
Study NCT04615078 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ETAPES Program
Description: The Chronic Care Connect Pneumology is a remote medical monitoring solution, combining:~* A technical solution for the transmission and analysis of ventilator data, leading to alerts generated by an algorithm ;~* An organizational solution relying on a nurse call center.
Study NCT05462236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinodasertib
Description: MNK inhibitor
Study NCT05462236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: PD-1 Inhibitor
Study NCT05462236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Topoisomerase inhibitor
Study NCT04817176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program
Description: Experimental Arm: The program is a 6-week group, telehealth intervention for older adults with possible MCI. The intervention uses Motivational interviewing and cognitive behavioral therapy strategies to enhance motivation and help participants overcome personal obstacles to following health-behavior recommendations. Specifically, the program examines the use of a Mediterranean ketogenic type of nutrition to target mild cognitive impairment. The intervention is designed to disseminate practical information to help older adults learn how to incorporate healthy Mediterranean ketogenic nutrition into their lifestyle.
Study NCT04817176 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ketogenic Nutrition Program
Description: Active Comparator Arm: 6-week group, telehealth intervention for older adults. The intervention is designed to disseminate practical information to help older adults learn how to incorporate healthy Mediterranean ketogenic nutrition into their lifestyle.
Study NCT03360019 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Activlink insole
Description: Dementia patients will wear the provided insole inserted into their own shoes. The insole will have a small electronic sensor that measures acceleration, foot force, and/or orientation.
Study NCT03360019 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Activlink Phone Application
Description: Smartphone tool used for monitoring location
Study NCT05355077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JT001 200mg Bid
Description: JT001 (VV116):200 mg,oral,Twice a day,6 consecutive days and the last administration will be given in the morning on Day 6
Study NCT05355077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JT001 400mg Bid
Description: JT001 (VV116):400 mg,oral,Twice a day,6 consecutive days and the last administration will be given in the morning on Day 6
Study NCT05355077 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JT001 600mg Bid
Description: JT001 (VV116):600 mg,oral,Twice a day,6 consecutive days and the last administration will be given in the morning on Day 6
Study NCT06144203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will complete either a 30-minute bout of light-, moderate-, or high-intensity aerobic exercise at one of the visits.
Study NCT04949282 — intervention group
Intervention type: DRUG
Intervention: Lutetium [177Lu] oxodotreotide/dotatate
Description: Radiopharmaceutical solution for infusion (7.4 GBq of Lutathera per 30 ml vial)
Study NCT04949282 — intervention group
Intervention type: DEVICE
Intervention: Lutetium [177Lu] oxodotreotide/dotatate
Description: Radiopharmaceutical solution for infusion (7.4 GBq of Lutathera per 30 ml vial)
Study NCT04712864 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LB1901
Description: LB1901 - an autologous CD4-targeted CAR-T immunotherapy
Study NCT05680077 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
Description: Blood samples from participants in both groups were collected and methylation tests were performed according to the kit instructions.
Study NCT01243515 — intervention group
Intervention type: DEVICE
Intervention: Non-Invasive Central Venous Pressure monitor
Description: An adhesive patch (connected to the Mespere NICVP monitor) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with CVP values obtained by physical examination (standard clinical practice)
Study NCT01243515 — intervention group
Intervention type: PROCEDURE
Intervention: Physical examination of jugular vein
Description: Physicians assess CVP using the jugular vein of the subject
Study NCT06484283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meditation
Description: Guided meditation will be applied within the scope of the study. A guided meditation video prepared by a Yoga Alliance-certified researcher will be used for this intervention. Guided meditation aims to ensure being in the moment (here and now) with the help of breathing. Meditation practice will take participants 10 minutes.
Study NCT05217602 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AC+ARwdC
Description: The Calm app is downloadable by participants onto their smartphone to access meditations and other Calm app features during the intervention period. Participants in the AC+ARwdC group will watch a video with information about the study, conditional rewards, and how to create an anchoring plan for their meditation habit. Weekly text message reminders will be sent during the intervention period to reinforce use of the anchoring plan. Participants in the AC+ARwdC group will be offered incentives for using their anchoring plan during the intervention period and for completing the baseline, post-intervention, and follow-up surveys.
Study NCT05217602 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AC+RwdC
Description: The Calm app is downloadable by participants onto their smartphone to access meditations and other Calm app features during the intervention period. Participants in the AC+RwdC group will watch a video with information about the study, conditional rewards, and how to create an anchoring plan for their meditation habit. Weekly text message reminders will be sent during the intervention period to reinforce use of the anchoring plan. Participants in the AC+RwdC group will be offered incentives for meditating during the intervention period and for completing the baseline, post-intervention, and follow-up surveys.
Study NCT05217602 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Calm Control (UC)
Description: The Calm app is downloadable by participants onto their smartphone to access meditations and other Calm app features during the intervention period. Participants in the UC group will watch a video with information about the study and how to create an anchoring plan for their meditation habit. Participants in the UC group will be offered incentives for completing the baseline, post-intervention, and follow-up surveys.
Study NCT04973657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VK0214
Description: API in capsule
Study NCT04973657 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: API in capsule
Study NCT05125302 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-Matching Ubrogepant
Description: Oral Tablet
Study NCT06485401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADC189
Description: 45 mg per tablet, oral administration, single dose.
Study NCT05769777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlitelimab
Description: Pharmaceutical form: Solution for injection; Route of administration: Subcutaneous (SC)